The US Food and Drug Administration (FDA) has expanded the emergency use authorisation (EUA) for Pfizer and BioNTechs Covid-19 vaccine to include adolescents aged 12 to 15 years.
The post US FDA approves emergency use of Pfizer-BioNTech Covid-19 vaccine in adolescents appeared first on ...

https://www.pharmaceutical-business-review.com/news/fda-pfizer-biontech-vaccine-adolescents/

#PharmaceuticalBusinessReview